DCT

1:21-md-03017

In re: Xarelto (Rivaroxaban) ('310) Patent Litigation

General
Filed
12/10/21
Cause of ActionPatent Infringement
SectorBiotech
StatusOpen
Patent Owner
Operating Company (W)
Nature of Suit835 ANDA
Judge
Period
PO Win Rate
11/01/23 - now
36%
10/04/23 - 11/01/23
--
12/28/21 - 10/04/23
36%
Defendant
Attorney
Name
Ratings
L5
A
L5
A
L4
B
L5
A
L5
A
L5
A
L5
E
L5
B
L5
E
L4
D
L5
C
L4
E
L2
E
L2
E
--
--
--
--
--
--
--
--
--
L4
E
L5
E
L2
A
L4
E
L4
C
L2
A
L4
E
L5
E
L5
E
L3
B
--
--
--
L3
C
L5
D
L4
A
L4
B
L4
C
L2
A
L1
C
L1
D
L3
D
L3
E
L2
D
L3
D
L5
A
L3
A
--
--
--
L3
E
L5
E
L2
A
L2
E
L1
E
--
--
--
--
--
--
L3
E
L5
E
L3
E
L5
E
L5
E
L2
D
L4
E
L1
D
--
--
--
L2
E
L4
C
L2
B
L2
E
--
--
--
L1
C
L1
C
L1
E
L4
E
L4
E
L3
E
L3
E
--
--
--
L1
C
No Attorneys